Mizuho MedyMIZUHO MEDY CO.,LTD.4595東証スタンダード医薬品FY ending Dec 2025, non-consolidated, J-GAAP

Mizuho Medy FY ending Dec 2019 results

Mizuho Medy brought in ¥6.43B in revenue.

Out of every ¥100 of sales, about ¥17 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Mizuho Medy sells, how much goes where, and how much is kept.

FY ending Dec 2019
Cost of sales
¥33
SG&A
¥50
Operating profit
¥17
Net profit kept
¥14

Margin funnel (derived from reported values)Gross margin 67.5% → Operating margin 17.3% → Net margin 13.6%

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第47期(2023/01/01-2023/12/31)

    ID S100T4JZ2024-03-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第45期(令和3年1月1日-令和3年12月31日)

    ID S100NPM42022-03-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第44期(令和2年1月1日-令和2年12月31日)

    ID S100L1D32021-03-29Open

Extracted from XBRL: 40 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.